CC
MNTA

Carlson Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Carlson Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-250,776
Closed -$13.2M – 223
2020
Q3 		$13.2M Buy
+250,776
New +$10.4M 0.38% 86

Carlson Capital's MNTA Position: Q4 2020 in Review

Carlson Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 250,776 shares — an estimated $13.2M sold.

Carlson Capital first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $13.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Carlson Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Carlson Capital sold 250,776 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $13.2M.
  • Carlson Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Carlson Capital's Momenta Pharmaceuticals, Inc. position peaked at $13.2M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Carlson Capital's 13F filing for Q4 2020, filed 12 Feb 2021.